EU GMP Annex 15 (2015) describes three approaches to process validation: the traditional one, with a justified number of batches under routine conditions; continuous process verification for products developed by quality by design; and a hybrid of the two. Ongoing process verification should follow whichever is used.
"Quality is QA's job" is not how the GMP texts read. The 2013 text of EU GMP Chapter 1 makes the quality objective the responsibility of senior management, with staff in many departments taking part. Chapter 2 lists qualification and maintenance of premises and equipment among the duties the heads of Production and Quality Control generally have.
ICH Q2(R2) says validation demonstrates that an analytical procedure is fit for its intended purpose. A study typically shows specificity or selectivity, a range with suitable response and lower limits, accuracy and precision; robustness is typically evaluated in development under ICH Q14. Validated for one sample type does not mean validated for another.
Cleaning validation is often reduced to showing the previous product is gone. EU GMP Annex 15 (2015) also says limits should be established for cleaning agents, microbial and endotoxin risk should be considered when protocols are developed, and the times before and after cleaning should be used to define dirty and clean hold times.
Analytical methods are often the last work package in a product transfer. The WHO guideline (TRS 1044, Annex 4) says analytical procedures, including those for cleaning residue samples where applicable, should be implemented at the testing laboratory before process validation samples are tested. That takes qualified laboratory equipment and trained analysts ahead of the first batch.
An assessor reads what stands behind the registration batches. By the time the first one is made, five things should be true at the receiving site: equipment and rooms qualified, analytical procedures transferred, specifications and suppliers approved, the master batch record issued and operators trained. Each needs a signed document behind it.
An ISO 9001 certificate shows that a supplier's quality management system was audited within a stated scope. It does not show that the equipment or service you bought meets your requirement. Supplier qualification assesses what you buy, against your URS, to a depth set by risk: questionnaire, audit or factory hold points.
A screenshot with no date, tag or user proves little. Evidence attached to an executed protocol should pass five checks: that it shows system, tag, date, time and user, that it is legible and uniquely referenced, that the test step cites it, that the tester signed and dated it, and that the raw data is retained.
ICH M4 makes Modules 2 to 5 of the CTD common in format, but Module 1 is region specific. The ASEAN format, the ACTD, arranges the content in four parts, and the ASEAN stability guideline gives 30 °C/75% RH as the general long-term condition. Fix the target markets early.
Continued process verification is the FDA's Stage 3: assurance during routine production that the process remains in a state of control. EU GMP Annex 15 (2015) calls it ongoing process verification. Continuous process verification, defined in ICH Q8(R2), is an alternative approach to validation. Write the phrase out and cite its source.
Sampling is the fourth step of a cleaning validation. Before any swab, EU GMP Annex 15 (2015 text) expects a justified worst-case product, a carryover limit based on a toxicological evaluation, and sampling locations with recovery shown for each surface and method. Hold times belong to the run, and manual cleaning should be confirmed at a justified frequency.
Two ideas in ASTM E2500 shorten qualification. Subject matter experts plan, execute and review verification, and in ISPE's summary of the 2025 edition the quality unit approves the plans and the final acceptance. Vendor documentation may be used as evidence if the vendor has been assessed. EU GMP Annex 15 (2015 text) allows some FAT tests to stand at IQ/OQ where justified.